✦ LIBER ✦

Non-invasive MRS in new anticancer drug development

✍ Scribed by Paul Workman; Ross J. Maxwell; John R. Griffiths

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 302 KB
Volume: 5
Category: Article
ISSN: 0952-3480
DOI: 10.1002/nbm.1940050513

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ceramide Analogues in Apoptosis: A New S

Ceramide Analogues in Apoptosis: A New Strategy for Anticancer Drug Development

✍ Marco Macchia; Simone Bertini; Stefano Fogli; Elisa Giovannetti; Filippo Minutol 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 57 KB 👁 1 views

MR in oncology drug development

✍ Susan M. Galbraith 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

Targeting Cytochrome P450 Enzymes: A New

Targeting Cytochrome P450 Enzymes: A New Approach in Anticancer Drug Development

✍ Robert D. Bruno; Vincent C. O. Njar 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 11 KB 👁 1 views

On the role of MRS in drug development

✍ Paul M. J. McSheehy 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB 👁 2 views

An excellent review of the role of MR in drug development was published this year in NMR in Biomedicine, and elegantly expounded upon at the recent 7th Conference of the ISMRM, Philadelphia. 1 The review discussed and presented detailed evidence of the current and potential contribution of NMR to th

Induction of Cell Differentiation and De

Induction of Cell Differentiation and Development of New Anticancer Drugs

✍ Noriko Takahashi 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 24 KB

Recent advances in pharmacogenetic appro

Recent advances in pharmacogenetic approaches to anticancer drug development

✍ Nicola F. Smith; William D. Figg; Alex Sparreboom 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB